J&J Avoids Risky Opioid Trial With ‘Chump Change’ Ohio Deal
Johnson & Johnson agreed to pay more than $20 million to avoid the first federal trial in which it faced accusations of helping fuel the opioid epidemic by mishandling its painkillers. Under the deal, announced late Tuesday, J&J will pay …